Results 191 to 200 of about 222,862 (245)

Nanomedicines and the future of glioma [PDF]

, 2015
Lalatsa, Aikaterini, Moreira Leite, Diana, Pilkington, Geoffrey John   +2 more
core   +1 more source

Nanomaterial‐Integrated 3D Biofabricated Structures for Advanced Biomedical Applications

Macromolecular Materials and Engineering, EarlyView.
This review investigates the integration of nanomaterials into 3D biofabricated structures, highlighting the potential in tissue regeneration, wound healing, and cancer therapy. It discusses key techniques, including bioprinting and electrospinning, while addressing challenges such as biocompatibility, scalability, and regulatory barriers.
Mustafijur Rahman, Tanvir Mahady Dip, Md Golam Nur, Md Hasibul Hossain, Finn Snow, Nusrat Binta Hossain, Azadeh Mirabedini, Anita Quigley, Rajiv Padhye, Shadi Houshyar   +9 more
wiley   +1 more source

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First-Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study. [PDF]

Thorac Cancer
Li X, Shi J, Zhu J, Zhu J, Yan F, Liu D, Cao G.   +6 more
europepmc   +1 more source

Corrigendum to "An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations": [ESMO Open 10 (2025) 104106]. [PDF]

ESMO Open
Kim KH, Park C, Beom SH, Kim MH, Kim CG, Kim HR, Jung M, Shin SJ, Rha SY, Kim HS.   +9 more
europepmc   +1 more source

Protein glycosylation in lung cancer from a mass spectrometry perspective

Mass Spectrometry Reviews, EarlyView.
Abstract Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer.
Mirjam Balbisi, Simon Sugár, Lilla Turiák   +2 more
wiley   +1 more source

Safety and Efficacy of a Paclitaxel-Coated Balloon for the Treatment of Symptomatic Patients with Long Superficial Femoral Artery Disease. [PDF]

Vasc Health Risk Manag
Sbarzaglia P, Galli M, Tenti E, Sangiorgi D, Lunetto ML, Russo P, Liso A, Pernice V, Micari A, Castriota F.   +9 more
europepmc   +1 more source

Mass Spectrometry Structural Proteomics Enabled by Limited Proteolysis and Cross‐Linking

Mass Spectrometry Reviews, EarlyView.
ABSTRACT The exploration of protein structure and function stands at the forefront of life science and represents an ever‐expanding focus in the development of proteomics. As mass spectrometry (MS) offers readout of protein conformational changes at both the protein and peptide levels, MS‐based structural proteomics is making significant strides in the
Haiyan Lu, Zexin Zhu, Lauren Fields, Hua Zhang, Lingjun Li   +4 more
wiley   +1 more source

Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease. [PDF]

Sci Rep
Chen Y, Dong K, Song Y, Sun L, Zheng M, Yin H, Zhang J, Wang W, Meng Y, Li W, He X, Zhao W, Han J.   +12 more
europepmc   +1 more source

Four‐gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma

Molecular Carcinogenesis, EarlyView.
ABSTRACT Brain metastasis has a high incidence and poor prognosis in lung adenocarcinoma (LUAD). We sought to identify genes associated with LUAD brain metastasis and with the prognosis of patients with LUAD. Differential gene expression analysis was performed on LUAD patients with and without distant metastasis from the Cancer Genome Atlas (TCGA ...
Zheng Gong, Fengyuan Yu, Chen Li, Bingying Zhao, Miaowei Wen, Shanshan Zhang, Zhezhe Xu, Ailu Wu, Rukun Zang, Yuan Li, Hongwei Li, Yipeng Song   +11 more
wiley   +1 more source

miR-126-5p suppresses HeLa and Ishikawa cell proliferation and migration via the RICTOR/AKT pathway. [PDF]

Discov Oncol
Zhang X, Yang Y, Li Y, Zhang W, Song X.
europepmc   +1 more source